Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.
Fiche du document
- doi: 10.1016/j.dib.2018.11.083
- issn: 2352-3409
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.dib.2018.11.083
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/30761338
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2352-3409
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_0F6AAF8562C26
info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/
Sujets proches
AssessmentCiter ce document
F. Herrera-Gómez et al., « Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation. », Serveur académique Lausannois, ID : 10.1016/j.dib.2018.11.083
Métriques
Partage / Export
Résumé
This article presents unrevealed details of the systematic review process of the article "The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review" (Herrera-Gómez et al., 2018). Eligibility criteria guiding searches and study selection, the risk of bias assessment, the assessment of medicine-test codependency (evaluation of the body of evidence), and meta-analytic calculations are provided. The data allows other researchers, particularly those involved in experiments on Translational Epidemiology applied to Pharmacology, to corroborate and extend our assessments.